The Peripal team is delighted, that after intensive development in collaboration with ETH Zurich and genuine PD patients, the PeriSafe® device for patients with peritoneal dialysis has received approval for the European market. The PeriSafe® device can be used in PD patients as of now, this can help more patients to undergo home dialysis treatments and can lower healthcare costs.
New Swiss Home Dialysis System Receives Marketing Approval: PeriSafe® Helps Thousands of Chronically Ill Kidney Patients With Peritoneal Dialysis. It lowers healthcare costs and improves the quality of life for those affected.
The Swiss medtech startup Peripal AG introduces an innovative auxiliary device for peritoneal dialysis patients. After successfully developing the device in collaboration with ETH Zurich, Peripal AG received the seal of approval to introduce it on the European market. Now patients can undergo home dialysis treatments both more safely and more easily.
Read more below
March 27, 2019